You are currently browsing the archives for 6 January 2017.
Displaying 1 entry.

In recent years.

The use of melatonin to regulate sleep is not the only working at the Institute of Biotechnology of the UGR conducted. In recent years, professors Acu? A Escames and have demonstrated that this substance is also useful to slow down the aging of cells to treat diseases such as Parkinson’s disease and to slow cell death by severe infectious processes that affect the entire organism technically known to causes sepsis. She is currently working on a clinical trial of Phase II, the therapeutic of melatonin in septic shock patients, finances finances of the Health Institute Carlos III.

Ability Medicines Agency in 2007 authorized the use of melatonin for this type of. , after years of debate about the convenience of this measure Where there at the appointed hour.